CG MedTech Co.,Ltd. Statistics

Total Valuation

CG MedTech Co.,Ltd. has a market cap or net worth of KRW 105.53 billion. The enterprise value is 87.77 billion.

Market Cap	105.53B
Enterprise Value	87.77B

Important Dates

The next estimated earnings date is Friday, March 21, 2025.

Earnings Date	Mar 21, 2025
Ex-Dividend Date	n/a

Share Statistics

CG MedTech Co.,Ltd. has 103.26 million shares outstanding. The number of shares has decreased by -20.09% in one year.

Current Share Class	n/a
Shares Outstanding	103.26M
Shares Change (YoY)	-20.09%
Shares Change (QoQ)	+124.54%
Owned by Insiders (%)	0.16%
Owned by Institutions (%)	n/a
Float	42.21M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.94
PB Ratio	1.37
P/TBV Ratio	1.59
P/FCF Ratio	116.53
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 22.44, with an EV/FCF ratio of 96.92.

EV / Earnings	-49.02
EV / Sales	2.48
EV / EBITDA	22.44
EV / EBIT	39.63
EV / FCF	96.92

Financial Position

The company has a current ratio of 5.49, with a Debt / Equity ratio of 0.07.

Current Ratio	5.49
Quick Ratio	3.69
Debt / Equity	0.07
Debt / EBITDA	1.18
Debt / FCF	5.10
Interest Coverage	4.13

Financial Efficiency

Return on equity (ROE) is -3.15% and return on invested capital (ROIC) is 1.98%.

Return on Equity (ROE)	-3.15%
Return on Assets (ROA)	1.62%
Return on Capital (ROIC)	1.98%
Revenue Per Employee	321.70M
Profits Per Employee	-16.28M
Employee Count	110
Asset Turnover	0.41
Inventory Turnover	1.60

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -13.39% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-13.39%
50-Day Moving Average	1,200.94
200-Day Moving Average	1,403.03
Relative Strength Index (RSI)	37.49
Average Volume (20 Days)	311,975

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, CG MedTech Co.,Ltd. had revenue of KRW 35.39 billion and -1.79 billion in losses. Loss per share was -26.60.

Revenue	35.39B
Gross Profit	15.59B
Operating Income	2.21B
Pretax Income	-1.88B
Net Income	-1.79B
EBITDA	3.91B
EBIT	2.21B
Loss Per Share	-26.60

Full Income Statement

Balance Sheet

The company has 22.00 billion in cash and 4.62 billion in debt, giving a net cash position of 17.38 billion or 168.32 per share.

Cash & Cash Equivalents	22.00B
Total Debt	4.62B
Net Cash	17.38B
Net Cash Per Share	168.32
Equity (Book Value)	70.02B
Book Value Per Share	748.23
Working Capital	33.56B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 2.55 billion and capital expenditures -1.64 billion, giving a free cash flow of 905.63 million.

Operating Cash Flow	2.55B
Capital Expenditures	-1.64B
Free Cash Flow	905.63M
FCF Per Share	8.77

Full Cash Flow Statement

Margins

Gross margin is 44.05%, with operating and profit margins of 6.26% and -5.06%.

Gross Margin	44.05%
Operating Margin	6.26%
Pretax Margin	-5.32%
Profit Margin	-5.06%
EBITDA Margin	11.06%
EBIT Margin	6.26%
FCF Margin	2.56%

Dividends & Yields

CG MedTech Co.,Ltd. does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	20.09%
Shareholder Yield	20.09%
Earnings Yield	-2.60%
FCF Yield	0.86%

Stock Splits

The last stock split was on August 5, 2022. It was a forward split with a ratio of 5.

Last Split Date	Aug 5, 2022
Split Type	Forward
Split Ratio	5

Scores

CG MedTech Co.,Ltd. has an Altman Z-Score of 4.4.

Altman Z-Score	4.4
Piotroski F-Score	n/a